ANAVEX2-73 for Treatment of Early Alzheimer's Disease

NCT03790709 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

509

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: High dose ANAVEX2-73
DRUG: Mid dose ANAVEX2-73
DRUG: Placebo oral capsule

Sponsor

Anavex Life Sciences Corp.

Collaborators

[object Object]
[object Object]
[object Object]